T-cell therapy offers lasting cure prospects, scientists say

OvaCure supports advances in immunotherapy approaches. It has shown great results in some cancer forms and OvaCure scientist are now applying T-cell therapy treatments in ovarian cancer patients - for the first time in the world.

Immunotherapy approaches are currently being tested in the clinical phases of several trials, yet there is great hope in its potential to cure cancer patients.

"A revolutionary cancer therapy that uses the body’s own immune cells to attack metastatic tumours that have spread is being hailed as a “paradigm shift” in treatment of the disease."